Venture Visionary Partners’s iShares Biotechnology ETF IBB Stock Holding History

Venture Visionary Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,170	Closed	-$138K	–	956
2022 Q2	$138K	Sell	1,170 -480	-29%	-$57K	0.01%	535
2022 Q1	$214K	Sell	1,650 -260	-14%	-$33.9K	0.01%	465
2021 Q4	$291K	Sell	1,910 -30	-2%	-$4.64K	0.02%	419
2021 Q3	$313K	Hold	1,940	–	–	0.02%	396
2021 Q2	$317K	Buy	1,940 +140	+8%	+$21.6K	0.03%	377
2021 Q1	$271K	Hold	1,800	–	–	0.02%	383
2020 Q4	$272K	Buy	+1,800	New	+$257K	0.03%	327

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Venture Visionary Partners's IBB Position: Q3 2022 in Review

Venture Visionary Partners sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 1,170 shares — an estimated $138K sold.

Venture Visionary Partners first reported a position in IBB in Q4 2020 and held it in 7 quarters. The position peaked at $317K in Q2 2021. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Venture Visionary Partners reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
Venture Visionary Partners sold 1,170 iShares Biotechnology ETF shares in Q3 2022, an estimated $138K.
Venture Visionary Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 7 quarters.
Venture Visionary Partners's iShares Biotechnology ETF position peaked at $317K in Q2 2021.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.